Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage

British Journal of Cancer

Volumn 83, Issue 1, 2000, Pages 112-120

  Sharpe, C R ^a,b   Collet, J P ^a,b   McNutt, M ^c   Belzile, E ^a   Boivin, J F ^a,b   Hanley, J A ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Saskatchewan Health   (Canada)

Author keywords

Anti inflammatory agents, non steroidal; Breast neoplasms; Case control studies; Epidemiology

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0034039306     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1119     Document Type: Article

References (40)

1. Breslow NE and Day NE (1980) Statistical Methods in Cancer Research. Vol. 1 -The Analysis of Case - control Studies. International Agency for Research on Cancer: Lyon
2. Cain KC and Breslow NE (1988) Logistic regression analysis and efficient design for two-stage studies. Am J Epidemiol 128: 1198-1206
3. Collet J-P, Sharpe C, Belzile E, Boivin J-F, Hanley J and Abenhaim L (1999) Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer 81: 62-68
4. Connolly JM and Rose DP (1993) Effects of fatty acids on invasion through reconstituted basement membrane ('Matrigel') by a human breast cancer cell line. Cancer Lett 75: 137-142
5. Connolly JM, Liu XH and Rose DP (1996) Dietary linoleic acid-stimulated human breast cancer cell growth and metastasis in nude mice and their suppression by indomethacin, a cyclooxygenase inhibitor. Nutr Cancer 25: 231-240
6. Day NE, Byar DP and Green SB (1980) Overadjustment in case - control studies. Am J Epidemiol 112: 696-706
7. Egan KM, Stampfer MJ, Giovannucci E, Rosner BA and Colditz GA (1996) Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 88: 988-993
8. Folkman J (1995) The influence of angiogenesis research on management of patients with breast cancer. Breast Cancer Res Treat 36: 109-118
9. Friedman GD and Ury HK (1980) Initial screening for carcinogenicity of commonly used drugs. J Natl Cancer Inst 65: 723-733
10. Gammon MD, John EM and Britton JA (1998) Recreational and occupational physical activities and risk of breast cancer. J Natl Cancer Inst 90: 100-117
11. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R and Fraumeni JF (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85: 307-311
12. Han EK, Arber N, Yamamoto H, Lim JT, Delohery T, Pamukcu R, Piazza GA and Xing WQ (1998) Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Breast Cancer Res Treat 48: 195-203
13. Harris RE, Namboodiri KK, Stellman SD and Wynder EL (1995) Breast cancer and NSAID use: heterogeneity of effect in a case - control study. Prev Med 24: 119-120
14. Harris RE, Namboodiri KK and Farrar WB (1996) Non-steroidal anti-inflammatory drugs and breast cancer. Epidemiology 7: 203-205
15. Hubbard NE, Chapkin RS and Erickson KL (1988) Inhibition of growth and linoleate-enhanced metastasis of a transplantable mouse mammary tumor by indomethacin. Cancer Lett 43: 111-120
16. Hudson N, Balsitis M, Everitt S and Hawkey CJ (1995) Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs. Gut 37: 191-194
17. Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, Muss HB and Forman MR, Wesley MN, Blacklow RS, Kurman RJ, Dignam JJ, Edwards BK and Shapiro S, and other members of the Black/White Cancer Survival Study Group (1993) Breast cancer: factors associated with stage at diagnosis in black and white women. J Natl Cancer Inst 85: 1129-1137
18. Hwang D, Scollard D, Byrne J and Levine E (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90: 455-460
19. Isomäki HA, Hakulinen T and Joutsenlahti U (1978) Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chron Dis 31: 691-696
20. Khoo NKS, Chan FPH, Saarloos MN and Lala PK (1992) Immunotherapy of mammary adenocarcinoma metastases in C3H/HcN mice with chronic administration of cyclooxygenase inhibitors alone or in combination with IL-2. Clin Exp Metastasis 10: 239-252
21. Krogh CME (ed) (1995) Compendium of Pharmaceuticals and Specialities, 30th edn. Canadian Pharmaceutical Association: Ottawa
22. Lala PK, Al-Mutter N and Orucevic A (1997) Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice. Int J Cancer 13: 371-380
23. MacMahon B and Trichopoulos D (1996) Epidemiology, Principles and Methods, 2nd edn. Little, Brown: Boston
24. Mickey RM and Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129: 125-137
25. Miettinen OS (1985) Theoretical Epidemiology. Principles of Occurrence Research in Medicine. Delmar: Albany
26. Parkin DM, Whelan SL, Ferlay J, Raymond L and Young J (eds) (1997) Cancer Incidence in Five Continents, Vol. VII. International Agency for Research on Cancer: Lyon
27. Rawson NSB, D'Arcy C, Blackburn JL, Bowen RC, Wallace SM, Downey W and Senft D (1992) Epidemiologic research using linked computerized health care datafiles in Saskatchewan, Canada. Technical report series. In Report #2. Psychiatric Pharmacoepidemiology Research Consortium: Saskatoon
28. Richardson JL, Langholz B, Bernstein L, Burciaga C, Danley K and Ross RK (1992) Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer 65: 922-926
29. Risch HA and Howe GR (1994) Menopausal hormone usage and breast cancer in Saskatchewan: a record linkage study. Am J Epidemiol 139: 670-683
30. Robertson FM, Parrett ML, Joarder FS, Ross M, Abou-Issa HM, Alshafie G and Harris RE (1998) Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Lett 122: 165-175
31. Schreinemachers DM and Everson RB (1994) Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology 5: 138-146
32. Sharpe CR (1999) Population-based Case - control Study of the Effects of Non-steroidal Anti-inflammatory Drugs on the Risk of Breast Cancer. PhD thesis. McGill University: Montréal
33. Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH and Wagner G, editors (1992) TNW Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours, 3rd edn, 2nd revision. Springer-Verlag: Berlin
34. Taketo MM (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (Part I). J Natl Cancer Inst 90: 1529-1536
35. Thompson HJ, Briggs S, Paranka NS, Piazza GA, Brendel K, Gross PH, Sperl GJ, and Pamukcu R (1995) Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. J Natl Cancer Inst 87: 1259-1260
36. Thun MJ, Namboodiri MM, Calle EE, Flanders WD and Heath CW (1993) Aspirin use and risk of fatal cancer. Cancer Res 53: 1322-1327
37. Thune I, Brenn T, Lund E and Gaard M (1997) Physical activity and the risk of breast cancer. N Engl J Med 336: 1269-1275
38. Vainio H and Morgan G (1998) Cyclooxygenase 2 and breast cancer prevention. Br Med J 317: 828
39. Walter SD and Day NE (1983) Estimation of the duration of a preclinical disease-state using screening data. Am J Epidemiol 118: 865-886
40. 1 and copper in angiogenesis. J Natl Cancer Inst 69: 475-482